Reyvow 100 mg/1
lasmiditan · TABLET · Eli Lilly and Company
No Recall History
Plain English
Reyvow is a tablet containing lasmiditan at 100 mg/1, taken oral. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Reyvow
- Generic Name
- lasmiditan
- NDC Code (Product)
0002-4491- Manufacturer
- Eli Lilly and Company
- Strength
- 100 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule V (Controlled)
- Application #
- NDA211280
- Marketing Start
- 10/11/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Reyvow used for?
Reyvow contains lasmiditan. It is a tablet taken oral. Consult your doctor for specific uses.
Is Reyvow a controlled substance?
Yes, Reyvow is classified as CV under the DEA Controlled Substances Act.
What is the generic name for Reyvow?
The generic name for Reyvow is lasmiditan. There are no other listed brand versions of lasmiditan.
What is the NDC code for Reyvow 100 mg/1?
The NDC (National Drug Code) for Reyvow 100 mg/1 is 0002-4491, listed by Eli Lilly and Company.
Other Reyvow Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)